Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
CGON Cg Oncology Inc.
- Stocks
- Healthcare
- NASDAQ: CGON
Price (delayed)
$25.43
Market cap
$1.94B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.51
Enterprise value
$1.9B
We are a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. Our product candidate, cretostimogene, is initially in
Highlights
CGON's EPS has soared by 88% YoY but it is down by 7% from the previous quarter
CGON's revenue is down by 42% since the previous quarter but it is up by 23% year-on-year
Cg Oncology's debt has surged by 156% YoY
Cg Oncology's net income has shrunk by 86% YoY and by 20% QoQ
Key stats
What are the main financial stats of CGON
Market
Valuations
Earnings
Shares outstanding
76.23M
Market cap
$1.94B
Enterprise value
$1.9B
Price to earnings (P/E)
N/A
Price to book (P/B)
2.75
Price to sales (P/S)
2,926.66
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2,867.03
Revenue
$662,000
Gross profit
$662,000
Operating income
-$134.4M
Net income
-$105.56M
EBIT
-$105.56M
EBITDA
-$105.54M
Free cash flow
-$82.22M
Per share
Balance sheet
Liquidity
EPS
-$1.51
EPS diluted
-$1.51
Free cash flow per share
-$1.08
Book value per share
$9.25
Revenue per share
$0.01
TBVPS
$9.56
Total assets
$728.18M
Total liabilities
$23.42M
Debt
$1.04M
Equity
$704.76M
Working capital
$678.55M
Debt to equity
0
Current ratio
30.97
Quick ratio
30.42
Net debt/EBITDA
0.38
Margins
Efficiency
Dividend
EBITDA margin
-15,942.3%
Gross margin
100%
Net margin
-15,945.2%
Operating margin
-20,302.3%
Return on assets
-16.2%
Return on equity
-16.7%
Return on invested capital
-19.5%
Return on capital employed
-15%
Return on sales
-15,945.2%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
CGON stock price
How has the Cg Oncology stock price performed over time
Intraday
0.32%
1 week
7.12%
1 month
25.77%
1 year
-17.89%
YTD
-11.33%
QTD
3.84%
Financial performance
How have Cg Oncology's revenue and profit performed over time
Revenue
$662,000
Gross profit
$662,000
Operating income
-$134.4M
Net income
-$105.56M
Gross margin
100%
Net margin
-15,945.2%
Cg Oncology's net margin has shrunk by 106% QoQ and by 51% YoY
Cg Oncology's operating margin has shrunk by 102% QoQ and by 60% YoY
The operating income has dropped by 97% year-on-year and by 17% since the previous quarter
Cg Oncology's net income has shrunk by 86% YoY and by 20% QoQ
Price vs fundamentals
How does CGON's price correlate with its fundamentals
Growth
What is Cg Oncology's growth rate over time
Valuation
What is Cg Oncology stock price valuation
P/E
N/A
P/B
2.75
P/S
2,926.66
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2,867.03
CGON's EPS has soared by 88% YoY but it is down by 7% from the previous quarter
CGON's equity is up by 24% year-on-year but it is down by 3.9% since the previous quarter
The price to book (P/B) is 21% lower than the last 4 quarters average of 3.5
CGON's revenue is down by 42% since the previous quarter but it is up by 23% year-on-year
The stock's P/S is 3.3% more than its last 4 quarters average of 2833.2
Efficiency
How efficient is Cg Oncology business performance
CGON's ROS has plunged by 106% from the previous quarter and by 51% YoY
Cg Oncology's return on invested capital has shrunk by 68% YoY and by 10% QoQ
The ROE has declined by 31% year-on-year and by 14% since the previous quarter
The company's return on assets fell by 30% YoY and by 13% QoQ
Dividends
What is CGON's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for CGON.
Financial health
How did Cg Oncology financials performed over time
Cg Oncology's total liabilities has surged by 130% YoY and by 9% QoQ
Cg Oncology's current ratio has decreased by 47% YoY and by 12% from the previous quarter
Cg Oncology's debt is 100% lower than its equity
Cg Oncology's debt has surged by 156% YoY
CGON's equity is up by 24% year-on-year but it is down by 3.9% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.